Your browser doesn't support javascript.
loading
Phenotypic Screen with the Human Secretome Identifies FGF16 as Inducing Proliferation of iPSC-Derived Cardiac Progenitor Cells.
Jennbacken, Karin; Wågberg, Fredrik; Karlsson, Ulla; Eriksson, Jerry; Magnusson, Lisa; Chimienti, Marjorie; Ricchiuto, Piero; Bernström, Jenny; Ding, Mei; Ross-Thriepland, Douglas; Xue, Yafeng; Peiris, Diluka; Aastrup, Teodor; Tegel, Hanna; Hober, Sophia; Sivertsson, Åsa; Uhlén, Mathias; Strömstedt, Per-Erik; Davies, Rick; Holmberg Schiavone, Lovisa.
Afiliação
  • Jennbacken K; Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceutical R&D, AstraZeneca, Gothenburg, 43150 Mölndal, Sweden.
  • Wågberg F; Mechanistic Biology and Profiling, Discovery Sciences, R&D, AstraZeneca, Gothenburg, 43150 Mölndal, Sweden.
  • Karlsson U; Mechanistic Biology and Profiling, Discovery Sciences, R&D, AstraZeneca, Gothenburg, 43150 Mölndal, Sweden.
  • Eriksson J; Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceutical R&D, AstraZeneca, Gothenburg, 43150 Mölndal, Sweden.
  • Magnusson L; Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceutical R&D, AstraZeneca, Gothenburg, 43150 Mölndal, Sweden.
  • Chimienti M; Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceutical R&D, AstraZeneca, Gothenburg, 43150 Mölndal, Sweden.
  • Ricchiuto P; Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge CB40WG, UK.
  • Bernström J; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, 43150 Mölndal, Sweden.
  • Ding M; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, 43150 Mölndal, Sweden.
  • Ross-Thriepland D; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge CB40WG, UK.
  • Xue Y; Structure and Biophysics and Fragment screening, Discovery Sciences, R&D, AstraZeneca, Gothenburg, 43150 Mölndal, Sweden.
  • Peiris D; Attana AB, 11419 Stockholm, Sweden.
  • Aastrup T; Attana AB, 11419 Stockholm, Sweden.
  • Tegel H; Department of Protein Science, School of engineering Sciences in Chemistry, Biotechnology and Health, KTH-Royal Institute of Technology, 11421 Stockholm, Sweden.
  • Hober S; Department of Protein Science, School of engineering Sciences in Chemistry, Biotechnology and Health, KTH-Royal Institute of Technology, 11421 Stockholm, Sweden.
  • Sivertsson Å; Department of Protein Science, School of engineering Sciences in Chemistry, Biotechnology and Health, KTH-Royal Institute of Technology, 11421 Stockholm, Sweden.
  • Uhlén M; Department of Protein Science, School of engineering Sciences in Chemistry, Biotechnology and Health, KTH-Royal Institute of Technology, 11421 Stockholm, Sweden.
  • Strömstedt PE; Mechanistic Biology and Profiling, Discovery Sciences, R&D, AstraZeneca, Gothenburg, 43150 Mölndal, Sweden.
  • Davies R; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge CB40WG, UK.
  • Holmberg Schiavone L; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, 43150 Mölndal, Sweden.
Int J Mol Sci ; 20(23)2019 Nov 30.
Article em En | MEDLINE | ID: mdl-31801200
Paracrine factors can induce cardiac regeneration and repair post myocardial infarction by stimulating proliferation of cardiac cells and inducing the anti-fibrotic, antiapoptotic, and immunomodulatory effects of angiogenesis. Here, we screened a human secretome library, consisting of 923 growth factors, cytokines, and proteins with unknown function, in a phenotypic screen with human cardiac progenitor cells. The primary readout in the screen was proliferation measured by nuclear count. From this screen, we identified FGF1, FGF4, FGF9, FGF16, FGF18, and seven additional proteins that induce proliferation of cardiac progenitor cells. FGF9 and FGF16 belong to the same FGF subfamily, share high sequence identity, and are described to have similar receptor preferences. Interestingly, FGF16 was shown to be specific for proliferation of cardiac progenitor cells, whereas FGF9 also proliferated human cardiac fibroblasts. Biosensor analysis of receptor preferences and quantification of receptor abundances suggested that FGF16 and FGF9 bind to different FGF receptors on the cardiac progenitor cells and cardiac fibroblasts. FGF16 also proliferated naïve cardiac progenitor cells isolated from mouse heart and human cardiomyocytes derived from induced pluripotent cells. Taken together, the data suggest that FGF16 could be a suitable paracrine factor to induce cardiac regeneration and repair.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Miócitos Cardíacos / Proliferação de Células / Células-Tronco Pluripotentes Induzidas / Fatores de Crescimento de Fibroblastos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Miócitos Cardíacos / Proliferação de Células / Células-Tronco Pluripotentes Induzidas / Fatores de Crescimento de Fibroblastos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article